These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6015636)

  • 1. Immunoradioactive agent against cancer.
    Ghose T; Cerini M; Carter M; Nairn RC
    Br Med J; 1967 Jan; 1(5532):90-3. PubMed ID: 6015636
    [No Abstract]   [Full Text] [Related]  

  • 2. [Morphological evaluation of the internal organs of mice with Ehrlich carcinoma treated with rat agammaglobulin antisarcoma serum].
    Niepolomski W; Szczurek Z; Czaplicki J
    Patol Pol; 1972; 23(2):143-50. PubMed ID: 5034469
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibodies as carriers of anticancer agents.
    Rubens RD
    Lancet; 1974 Mar; 1(7856):498-9. PubMed ID: 4131895
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody formation for malignant tumor. II. Antigenicity of Ehrlich ascites tumor lipoprotein.
    Yamamoto Y; Tadatomo Y; Okamura S
    Acta Med Okayama (1952); 1970 Oct; 24(5):527-36. PubMed ID: 4256471
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined effect in the radiologic and immunologic treatment of a malignant homograft.
    Kano E
    Acta Radiol Ther Phys Biol; 1968 Jun; 7(3):209-29. PubMed ID: 5706063
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of Ehrlich ascites tumor growth by nucleoprotein. II. In vivo fate of the tumor cells.
    Bradshaw LJ; Webb DR
    J Natl Cancer Inst; 1969 Sep; 43(3):527-32. PubMed ID: 4980604
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of subcutaneous Ehrlich carcinoma by antihuman-somatotropic hormone serum of the horse as determined by the tumour-tetanus assay of the mouse.
    Lazarev AF; Schneeweiss U; Fabricius EM
    Arch Geschwulstforsch; 1976; 46(4):261-70. PubMed ID: 971044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Proteus vulgaris lipopolysaccharide on resistance of mice inoculated with tumor cells sensitized to Ehrlich carcinoma transplantation.
    Kato N; Ito S; Yamazaki M; Mizuno D
    Gan; 1973 Apr; 64(2):111-20. PubMed ID: 4124878
    [No Abstract]   [Full Text] [Related]  

  • 9. [Stimulation of cell division by Ehrlich carcinoma cell surface antibodies].
    Segarra M; Alfonso M; Subiza JL; Coll J
    Rev Esp Oncol; 1984; 31(2):205-13. PubMed ID: 6443683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antineoplastic immunological reactions in animals with Ehrlich's carcinoma].
    Bergamini G; D'Acunzo L; Fazio G; Giudici G
    Riv Patol Clin Sper; 1967; 8(4):477-88. PubMed ID: 5605966
    [No Abstract]   [Full Text] [Related]  

  • 11. [Natural resistance and induced resistance to ATPC + tumor in mice].
    Marconi P; Pitzurra M; Bistoni F; Iorio A
    Boll Ist Sieroter Milan; 1972; 51(1):27-43. PubMed ID: 5083003
    [No Abstract]   [Full Text] [Related]  

  • 12. Loss of cellular ATP as a measure of cytolytic activity of antiserum.
    Nungester WJ; Paradise LJ; Adair JA
    Proc Soc Exp Biol Med; 1969 Nov; 132(2):582-6. PubMed ID: 5389758
    [No Abstract]   [Full Text] [Related]  

  • 13. [The duration of the inhibitory influence of antironidase serum and its gamma-globulin fraction on the mitotic ACTIVITY OF TUMOR CELLS].
    Sukhorukikh SV
    Biull Eksp Biol Med; 1965 Nov; 60(11):96-8. PubMed ID: 4164707
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in the electrophoretic mobility of mouse lymphocytes, thymocytes, macrophages and tumour cells following immunisation.
    Hartveit F; Cater DB; Mehrishi JN
    Br J Exp Pathol; 1968 Dec; 49(6):634-47. PubMed ID: 5706992
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-cancerous activity and specificity of anti-embryonal serums].
    Sédallian JP
    C R Seances Soc Biol Fil; 1966; 160(11):2092-6. PubMed ID: 4228139
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interference "in vitro" of "Tween-80" on agglutination of tumor cells].
    Melan F; Testorelli C; Valenti L
    Arch Ital Patol Clin Tumori; 1968; 11(1):195-201. PubMed ID: 5754462
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the cell cycle of Ehrlich carcinoma cells transplanted into allogeneic and xenogeneic hosts.
    Janik P
    Arch Immunol Ther Exp (Warsz); 1969; 17(5):590-6. PubMed ID: 5370177
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody formation for malignant tumor. 3. Antigenicity of peptide of ribosomal digest in Ehrlich ascites tumor.
    Yamamoto Y; Jituiki D; Yabuki Y
    Acta Med Okayama (1952); 1970 Oct; 24(5):534-7. PubMed ID: 4256472
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of immunological factors on the antitumor action of 4-diphenylylglioxal in Ehrlich ascites cancer].
    Melan F; Testorelli C
    Arch Ital Patol Clin Tumori; 1969; 12(1):57-67. PubMed ID: 5396284
    [No Abstract]   [Full Text] [Related]  

  • 20. Preliminary report. Antigenicity of the mice Ehrlich ascitic tumor cell nuclei.
    Zitnan D; Cebecauer L; Ujházy V
    Neoplasma; 1969 Jun; 16(3):339-41. PubMed ID: 4981697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.